gold compounds + penicillamine + sulfasalazine

This is a combination of three distinct disease-modifying antirheumatic drugs (DMARDs) that are used in the treatment of rheumatoid arthritis. Each component has its own distinct properties, mechanisms of action, and side effect profiles: 1. **Gold compounds** (also called gold salts) have been used as a treatment for rheumatoid arthritis for many years. They work by suppressing inflammation and modifying the disease process. 2. **Penicillamine** (D-Penicillamine) has shown efficacy in the treatment of rheumatoid arthritis, particularly at higher doses. It is a chelating agent that may work by reducing certain immune responses and inflammation. 3. **Sulfasalazine** (Salazopyrine) has anti-inflammatory and immunomodulatory effects, with its active metabolites including sulfapyridine and 5-aminosalicylic acid. It appears to be well tolerated over long periods and is associated with fewer serious adverse effects compared to gold or penicillamine. While these drugs may sometimes be used in various combination approaches for rheumatoid arthritis, this specific three-drug combination is not commonly described as a standard treatment regimen in current practice, which tends to favor other DMARDs like methotrexate, sulfasalazine, and hydroxychloroquine.

Other names

gold compounds + penicillamine + salazopyrine